NEW YORK (Reuters Health)—New registry data should help reassure women with Crohn’s disease (CD) who need to continue infliximab during pregnancy that it won’t harm their baby. “The clinical condition of infants born to women with gestational infliximab exposure was similar to those without exposure,” the study team reports online July 19 in the American…
SLE Is a Leading Cause of Death Among Women
Systemic lupus erythematous (SLE) is a chronic inflammatory disease that predominantly affects women and can involve virtually any organ. The authors of this study analyzed secular trends and population characteristics associated with SLE mortality. Objective: Mortality statistics from the Centers for Disease Control and Prevention (CDC) are used for planning healthcare policy and allocating resources….
Nurse Practitioners Provide Advanced Care & Support
With their ability to provide treatment and manage chronic illnesses, nurse practitioners can aid rheumatologists in the care of their patients…
Switch to Electronic Health Records Tied to Fewer Hospital Deaths
(Reuters Health)—Hospitals that switch from paper to electronic health records may eventually see lower death rates than they had before, but a U.S. study also suggests that fatalities may first increase as the transition gets underway. Researchers examined the degree of digitization and 30-day death rates for patients age 65 and older at 3,249 hospitals…
Long-Term Apremilast Promising for Psoriatic Arthritis
In a long-term study, apremilast was well tolerated by patients with psoriatic arthritis, who showed sustained improvements for up to five years…
Pfizer-Lilly Pain Drug Meets Late-Stage Trial Goals
(Reuters)—An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of lowering pain in a late stage trial, the companies said on Wednesday, potentially offering a safer alternative to opioids. Opioid abuse has reached epidemic proportions in the United States and drugmakers have been looking for less addictive…
Private Practice in Rheumatology: Winners & Losers in the Workforce Numbers Game
In the U.S., the demand for rheumatologists has outpaced the supply of physicians. So how do private practices attract new physicians, and how are practices with physician vacancies managing?
Upadacitinib Promising for RA Patients
Upadacitinib proved safe and effective in RA patients who had inadequate responses to conventional disease-modifying anti-rheumatic drugs…
How Depression Affects the Cognitive Profile of Fibromyalgia Patients
New research evaluated the effect of depression on the cognition of fibromyalgia patients, finding that these patients have a distinct cognitive profile. Researchers note that emotional symptoms, such as depression and anxiety, are essential to the cognitive performance of fibromyalgia patients and that treating these symptoms may reduce cognitive impairment…
UHC Announces New Policy on National Drug Code Requirement
Effective Sept. 1, 2018, United Healthcare’s (UHC) new policy for National Drug Code (NDC) reimbursement will require providers to include additional drug-related codes submitted on the CMS-UB04 and the Electronic Data Interface (EDI) transaction 837i. All outpatient claims submitted to UHC commercial and UHC Medicare Advantage plans with a date of service on or after…
- « Previous Page
- 1
- …
- 321
- 322
- 323
- 324
- 325
- …
- 814
- Next Page »